Bertrand Bellier

1.9k total citations
47 papers, 1.4k citations indexed

About

Bertrand Bellier is a scholar working on Immunology, Epidemiology and Molecular Biology. According to data from OpenAlex, Bertrand Bellier has authored 47 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 14 papers in Epidemiology and 10 papers in Molecular Biology. Recurrent topics in Bertrand Bellier's work include Immunotherapy and Immune Responses (15 papers), T-cell and B-cell Immunology (12 papers) and Virus-based gene therapy research (8 papers). Bertrand Bellier is often cited by papers focused on Immunotherapy and Immune Responses (15 papers), T-cell and B-cell Immunology (12 papers) and Virus-based gene therapy research (8 papers). Bertrand Bellier collaborates with scholars based in France, Belgium and United States. Bertrand Bellier's co-authors include David Klatzmann, Fabien Pitoiset, Guillaume Churlaud, Charlotte Dalba, Michèlle Rosenzwajg, Béatrice Levacher, Roberta Lorenzon, Fadi Jebbawi, Thomas Vazquez and Véronique Thomas‐Vaslin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Bertrand Bellier

46 papers receiving 1.4k citations

Peers

Bertrand Bellier
Bertrand Bellier
Citations per year, relative to Bertrand Bellier Bertrand Bellier (= 1×) peers Paola Del Porto

Countries citing papers authored by Bertrand Bellier

Since Specialization
Citations

This map shows the geographic impact of Bertrand Bellier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bertrand Bellier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bertrand Bellier more than expected).

Fields of papers citing papers by Bertrand Bellier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bertrand Bellier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bertrand Bellier. The network helps show where Bertrand Bellier may publish in the future.

Co-authorship network of co-authors of Bertrand Bellier

This figure shows the co-authorship network connecting the top 25 collaborators of Bertrand Bellier. A scholar is included among the top collaborators of Bertrand Bellier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bertrand Bellier. Bertrand Bellier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sarazin, Marie, Julien Lagarde, Leonardo Cruz de Souza, et al.. (2024). The path to next-generation disease-modifying immunomodulatory combination therapies in Alzheimer’s disease. Nature Aging. 4(6). 761–770. 16 indexed citations
2.
Vazquez, Thomas, Fabien Pitoiset, Béatrice Levacher, et al.. (2023). Particulate antigens administrated by intranasal and intravaginal routes in a prime-boost strategy improve HIV-specific TFH generation, high-quality antibodies and long-lasting mucosal immunity. European Journal of Pharmaceutics and Biopharmaceutics. 191. 124–138. 2 indexed citations
3.
Bellier, Bertrand, et al.. (2022). A Thermostable Oral SARS-CoV-2 Vaccine Induces Mucosal and Protective Immunity. Frontiers in Immunology. 13. 837443–837443. 9 indexed citations
4.
Comarmond, Cloé, Marlène Garrido, Stanislas Pol, et al.. (2017). Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus–Induced Cryoglobulinemia Vasculitis. Gastroenterology. 152(8). 2052–2062.e2. 75 indexed citations
5.
Bonnet, Benjamin, J. Vigneron, Béatrice Levacher, et al.. (2016). Low-Dose IL-2 Induces Regulatory T Cell–Mediated Control of Experimental Food Allergy. The Journal of Immunology. 197(1). 188–198. 43 indexed citations
6.
Soares, Hugo R., Rute Castro, Ana F. Rodrigues, et al.. (2016). Tetraspanins displayed in retrovirus-derived virus-like particles and their immunogenicity. Vaccine. 34(13). 1634–1641. 13 indexed citations
7.
Dérian, Nicolas, Bertrand Bellier, Eliza Tsitoura, et al.. (2016). Early Transcriptome Signatures from Immunized Mouse Dendritic Cells Predict Late Vaccine-Induced T-Cell Responses. PLoS Computational Biology. 12(3). e1004801–e1004801. 6 indexed citations
8.
Courau, Tristan, Djamel Nehar-Belaid, Laura V. Flórez, et al.. (2016). TGF-β and VEGF cooperatively control the immunotolerant tumor environment and the efficacy of cancer immunotherapies. JCI Insight. 1(9). e85974–e85974. 101 indexed citations
9.
Churlaud, Guillaume, Fabien Pitoiset, Fadi Jebbawi, et al.. (2015). Human and Mouse CD8+CD25+FOXP3+ Regulatory T Cells at Steady State and during Interleukin-2 Therapy. Frontiers in Immunology. 6. 171–171. 155 indexed citations
10.
Six, Adrien, Bertrand Bellier, Véronique Thomas‐Vaslin, & David Klatzmann. (2011). Systems biology in vaccine design. Microbial Biotechnology. 5(2). 295–304. 35 indexed citations
11.
Ferreira, Helena Lage, Bénédicte Lambrecht, Steven Van Borm, et al.. (2010). Identification of a Dominant Epitope in the Hemagglutinin of an Asian Highly Pathogenic Avian Influenza H5N1 Clade 1 Virus by Selection of Escape Mutants. Avian Diseases. 54(s1). 565–571. 16 indexed citations
12.
Bellier, Bertrand, Christophe Huret, Delphine Desjardins, et al.. (2009). DNA vaccines expressing retrovirus-like particles are efficient immunogens to induce neutralizing antibodies. Vaccine. 27(42). 5772–5780. 31 indexed citations
13.
Marodon, Gilles, Delphine Desjardins, Claude Baillou, et al.. (2009). High diversity of the immune repertoire in humanized NOD.SCID.γc−/− mice. European Journal of Immunology. 39(8). 2136–2145. 45 indexed citations
14.
Desjardins, Delphine, Christophe Huret, Charlotte Dalba, et al.. (2009). Recombinant retrovirus‐like particle forming DNA vaccines in prime‐boost immunization and their use for hepatitis C virus vaccine development. The Journal of Gene Medicine. 11(4). 313–325. 25 indexed citations
15.
Dalba, Charlotte, Bertrand Bellier, Noriyuki Kasahara, & David Klatzmann. (2007). Replication-competent Vectors and Empty Virus-like Particles: New Retroviral Vector Designs for Cancer Gene Therapy or Vaccines. Molecular Therapy. 15(3). 457–466. 33 indexed citations
16.
Bégos, Arlette, et al.. (2006). Applications of Deactivated GC Columns for Analysis of Nitrogen-Containing Chemicals Related to the Chemical Weapons Convention. Journal of Chromatographic Science. 44(3). 162–166. 3 indexed citations
17.
Taysse, L., et al.. (2005). Peripheral ChE Inhibition Modulates Brain Monoamines Levels and c-fos Oncogene in Mice Subjected to a Stress Situation. Neurochemical Research. 30(3). 391–402. 9 indexed citations
18.
Bellier, Bertrand, Charlotte Dalba, Delphine Desjardins, et al.. (2005). DNA vaccines encoding retrovirus-based virus-like particles induce efficient immune responses without adjuvant. Vaccine. 24(14). 2643–2655. 46 indexed citations
19.
Thomas‐Vaslin, Véronique, Bertrand Bellier, José L. Cohen, et al.. (2000). PROLONGED ALLOGRAFT SURVIVAL THROUGH CONDITIONAL AND SPECIFIC ABLATION OF ALLOREACTIVE T CELLS EXPRESSING A SUICIDE GENE1. Transplantation. 69(10). 2154–2161. 12 indexed citations
20.
Boyer, Olivier, José L. Cohen, Bertrand Bellier, et al.. (2000). Transient control of a virus-induced immunopathology by genetic immunosuppression. Gene Therapy. 7(18). 1536–1542. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026